nivolumab,rigosertib
onconova therapeutics,SymBio pharmaceuticals,Knight Therapeutics,bms
['rigoser', 'nivo', 'lung', 'nivolumab', 'onconova therapeutics', '$ontx']
$ontx onconova therapeutics therapeutics announces updated data from investigator-sponsored phase 1/2a trial evaluating rigosertib in combination with nivolumab in advanced kras-mutated non-small cell lung cancer at the esmo cong #cancer
¬ Retweeting Bloomberg's Feed all in one place.

¬ Market & Stock Updates

¬ I'm Barry Bloomberg putting out the fastest updates!

¬ Making your life easier.